LifeMD, Inc. Cash Flow Statement
LFMD|13 years of annual SEC 10-K data (FY2013-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 13 fiscal years. All figures from audited SEC 10-K filings.
At a glance
Operating Cash Flow
$18M
FY2025
Free Cash Flow
$16M
FY2025
Capital Expenditures
$1M
Cash used for long-term assets
Dividends Paid
$3M
FY2025
LifeMD, Inc. generated $18M in operating cash flow and $16M in free cash flow in FY2025. Free cash flow margin was 10.4% of revenue.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score NaN (distress zone, below 1.23 threshold)
- Currently unprofitable: Net income is negative
- Cash-backed earnings: Operating cash flow exceeds net income
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -$21.4M | -$20.6M | -$45.5M | -$60.9M | -$58.6M | -$3.1M | -$1.2M | -$1.2M | -$1.1M | -$62.0K | -$460.5K | -$268.3K | -$445.6K |
| Depreciation & Amortization | $465.8K | $204.0K | $161.9K | $13.6K | $13.6K | - | - | - | - | $43.7K | $57.0K | $57.0K | $57.0K |
| Operating Cash Flow | $17.5M | $8.8M | -$22.9M | -$33.1M | -$12.1M | $251.4K | -$905.5K | -$817.2K | -$407.9K | -$295.1K | $33.4K | -$259.1K | -$229.7K |
| Capital Expenditures | $1.5M | $203.8K | $366.6K | $247.4K | $247.4K | - | - | - | - | - | - | - | - |
| Free Cash Flow | $16.0M | $8.6M | -$23.3M | -$33.3M | -$12.4M | - | - | - | - | - | - | - | - |
| Share Buybacks | $270.0K | - | - | - | - | $350.0K | - | $76.6K | - | - | - | - | - |
| Dividends Paid | $3.1M | $3.1M | $3.1M | $871.5K | $871.5K | - | - | - | - | - | $10.8K | - | - |
| FCF Margin | 10.4% | 5.7% | -19.6% | -35.9% | -33.2% | - | - | - | - | - | - | - | - |